a
Your trusted place for Sierra Leone and global news
HomeFeaturedGuinea Extends Ebola Ring Vaccine Trial to Sierra Leone

Guinea Extends Ebola Ring Vaccine Trial to Sierra Leone

Guinea Extends Ebola Ring Vaccine Trial to Sierra Leone

Reliable sources reaching this press states that The Guinean Ebola Ring Vaccine Trial has been extended to Sierra Leone as a move to stop the transmission across the region, our report confirms. (Photo: Focal Lead of the Vaccine Trial, Dr. James Russell)

Addressing participants in a recent opening ceremony of the training session at the Conference Hall of Brookfields Hotel in Freetown, the World Health Organization (WHO) Ebola Technical Coordinator Sierra Leone, Dr. Margaret Lamumu said that prior to the extension of the vaccine to Sierra Leone, the Ministry of Health and Sanitation (MoHS) and World Health Organization’s (WHO) Joint team visited five sites to make available the vaccine study, adding that expert trainers from the United Kingdom were targeted to do the training.

Chief Medical Officer, Dr. Brima Kargbo in group with the Vaccine Trial Team and participants

Chief Medical Officer, Dr. Brima Kargbo in group with the Vaccine Trial Team and participants

Dr. Margaret Lamumu

Dr. Margaret Lamumu

She inform her audience that as Sierra Leone gets to Ebola an free nation, the country still stands the risk of getting to be declared Ebola free and admonished participants to show commitment during the training.

The Chief Medical Officer of the Ministry of Health and Sanitation, Dr. Brima Kargbo also said that the use of the vaccine would help break the chain of transmission, and emphasize on the need to work collectively as a team to control further spread of the disease.

He noted that with the presence of the disease, Sierra Leone is still a worried nation and that if the disease is not contained in the three countries: Guinea, Liberia and Sierra Leone the fight still continues to making the region free.

Dr. Kargbo disclosed that a huge number of compatriots lost their lives during the height of the crisis of the outbreak, and positioned surveillance, community engagement and community ownership as one of the Ministry’s Post Recovery Strategy in meeting the challenges ahead.

Dr. James Russell, the Focal Lead of the Vaccine Trial also spoke about the efficacy and safety of the vaccine, adding that it is basically not for the general populace but targeting contact of an infected person with a complex protocol for Ebola patient in the community. This he said will avert spread and transmission. The acceptance and extension of the trial in Sierra Leone, by the Government he said shows commitment to end the disease in the country and extremely important for the Repaid Response Team.

Dr. Anders Nordstrom, WHO Country Representative

Dr. Anders Nordstrom, WHO Country Representative

The WHO Country Representative Dr. Anders Nordstrom reiterated the safety of the disease, its efficacy and underscored the importance of Research Trial in Guinea that has been extended to Sierra Leone.

According to reports, Nordstrom further said that this is a high quality initiative that demonstrates what the world can do and implored participants to show commitment.

JAK/KK/MOHS/SLENA

Stay with Sierra Express Media, for your trusted place in news!

© 2015, sierraexpressmedia.com. All rights reserved.

Share With:
Rate This Article
No Comments

Leave A Comment